Urupong/iStock via Getty Images Dear Baron Global Opportunity Fund Shareholder, Baron Global Opportunity Fund® (the Fund) declined 4.8% (Institutional Shares) during the first quarter, compared to the 3.2% decline for the MSCI ACWI Index (the Index), and the 7.7% decline for the MSCI ACWI Growth Index, the Fund's benchmarks. Annualized performance (%) for periods ended March 31, 2026† Fund Retail ...
Urupong/iStock via Getty Images Dear Baron Global Opportunity Fund Shareholder, Baron Global Opportunity Fund® (the Fund) declined 4.8% (Institutional Shares) during the first quarter, compared to the 3.2% decline for the MSCI ACWI Index (the Index), and the 7.7% decline for the MSCI ACWI Growth Index, the Fund's benchmarks. Annualized performance (%) for periods ended March 31, 2026† Fund Retail Shares1,2 Fund Institutional Shares1,2 MSCI ACWI Index 1 MSCI ACWI Growth Index 1 QTD 3 (4.86) (4.80) (3.20) (7.67) 1 Year 33.92 34.00 20.01 21.33 3 Years 20.54 20.77 16.58 18.03 5 Years (1.04) (0.83) 9.49 9.30 10 Years 13.72 13.97 11.33 13.12 Since Inception(4/30/2012) 11.93 12.17 10.16 11.71 Click to enlarge Performance listed in the table above is net of annual operating expenses. The gross annual expense ratio for the Retail Shares and Institutional Shares as of April 30, 2025 was 1.22% and 0.96%, respectively, but the net annual expense ratio was 1.16% and 0.91% (net of the Adviser's fee waivers, comprised of operating expenses of 1.15% and 0.90%, respectively, and interest expense of 0.01% and 0.01%, respectively), respectively. The performance data quoted represents past performance. Past performance is no guarantee of future results. The investment return and principal value of an investment will fluctuate; an investor's shares, when redeemed, may be worth more or less than their original cost. The Adviser waives and/or reimburses certain Fund expenses pursuant to a contract expiring on August 29, 2036, unless renewed for another 11-year term and the Fund's transfer agency expenses may be reduced by expense offsets from an unaffiliated transfer agent, without which performance would have been lower. Current performance may be lower or higher than the performance data quoted. For performance information current to the most recent month end, visit BaronCapitalGroup.com or call 1-800-99-BARON. Click to enlarge After three consecutive years of 25%-plus gains, we were li...
AndreyPopov Applied Aerospace & Defense ( AADX ), a supplier of engineering systems for defense and space programs, raised $650 million in its initial public offering after pricing shares near the upper end of its expected range, underscoring continued investor interest in aerospace and defense companies. The Huntsville, Alabama-based company sold 32.5 million shares at $20 each, according to a st...
AndreyPopov Applied Aerospace & Defense ( AADX ), a supplier of engineering systems for defense and space programs, raised $650 million in its initial public offering after pricing shares near the upper end of its expected range, underscoring continued investor interest in aerospace and defense companies. The Huntsville, Alabama-based company sold 32.5 million shares at $20 each, according to a statement released Tuesday. The offering was marketed at between $18 and $21 per share. Based on shares outstanding following the transaction, Applied Aerospace is valued at approximately $3.4 billion. The company develops components and subsystems used in military and space applications, including propulsion and power systems, missile hardware, launch vehicle landing systems and communications technologies designed for harsh operating environments. Its customers include U.S. government agencies and defense contractors. For investors, the offering provides another indicator of strong capital market demand for companies tied to defense modernization, missile systems and space infrastructure. Applied Aerospace enters the public market with a contract backlog approaching $1.1 billion, offering visibility into future revenue, while the IPO also highlights growing investor appetite for aerospace and defense businesses amid rising government spending and increased geopolitical tensions. Applied Aerospace reported a net loss of $15.1 million on revenue of $134.4 million during the first quarter, compared with a loss of $7.3 million on revenue of $111 million a year earlier. While sales increased year over year, losses also widened as the company continued to invest in growth. The company traces its current form to a series of acquisitions orchestrated by private equity owner Greenbriar Equity Group. Greenbriar acquired Applied Aerospace in 2022 and later combined it with PCX Aerosystems, another portfolio company serving the aerospace, defense and space industries. Applied Aerospace...
Wall Street traders expect a strong jobs report on Friday. That may not be enough to soothe them, as the war-fueled oil price shock increasingly shifts the focus toward inflation. The stock market, which is clocking one record after the next, has largely shrugged off months of elevated crude prices. Beneath the surface, worries are rising about just how persistent inflationary pressures are going ...
Wall Street traders expect a strong jobs report on Friday. That may not be enough to soothe them, as the war-fueled oil price shock increasingly shifts the focus toward inflation. The stock market, which is clocking one record after the next, has largely shrugged off months of elevated crude prices. Beneath the surface, worries are rising about just how persistent inflationary pressures are going to be — and what the Federal Reserve is going to do about it. Traders expect the central bank’s interest-rate decision on June 17 to be the S&P 500 Index ’s biggest event in the next month, followed by the consumer price index report on June 10, data compiled by Citigroup Inc. show. The options market is betting the gauge will move 0.6% in either direction on Friday, in what would be among the calmest jobs days in months. “The employment numbers aren’t as meaningful for traders because all eyes are back on the inflation metrics and how that may affect interest rates,” said Larry Benedict , chief executive of The Opportunistic Trader, a financial market-research firm. “A strong jobs figure creates another conundrum for the Fed as officials try to keep the economy from overheating.” Traders are looking to the job figures, due at 8:30 a.m. in Washington on Friday, for clues as to whether the labor market and wages are strengthening after consumer spending crept up in April . The consensus calls for a gain of 85,000, based on the median estimate in a Bloomberg survey of economists. The jobless rate probably held steady at 4.3%, while average hourly earnings are projected to have risen 0.3% from a month earlier. Steady momentum in the labor market comes on the back of persistent inflation that’s sapped incomes and pushed the saving rate to an almost four-year low. The setup has created a conundrum for traders looking to game out the Fed’s interest-rate path. Bond traders are pricing in a rate hike this year, a sign of conviction that new Fed chief Kevin Warsh will need to move q...
JHVEPhoto Western Digital ( WDC ) said on Wednesday that it has entered into separate agreements with some of its convertible note holders that are due in 2028. As part of the agreement, the holders said they will exchange approximately $858.4M in notes for an amount of cash equal to the sum of the notes; any accrued and unpaid interest on the notes; and a number of shares of Western Digital that ...
JHVEPhoto Western Digital ( WDC ) said on Wednesday that it has entered into separate agreements with some of its convertible note holders that are due in 2028. As part of the agreement, the holders said they will exchange approximately $858.4M in notes for an amount of cash equal to the sum of the notes; any accrued and unpaid interest on the notes; and a number of shares of Western Digital that correspond to the remaining value of notes if they had been converted using the volume-weighted average price from June 3 to June 4. The transactions are expected to close on or after June 5, 2026, Western Digital added. More on Western Digital Western Digital: Not Worth 20x P/E Adjusting For The Sandisk Stake Western Digital: Strong Margins, AI Story Intact Western Digital Corporation (WDC) Presents at Bank of America 2026 Global Technology Conference Transcript Notable analyst calls this week: Sandisk, Snowflake and Sensata among top picks Western Digital adds former Nvidia exec to board of directors
zorazhuang/iStock via Getty Images A Dutch court said it could hear a case brought by Greenpeace against U.S. pipeline company Energy Transfer ( ET ), as the environmentalist group seeks compensation for U.S. cases in which it said it was targeted by the company, Reuters reported Wednesday. The court said it had jurisdiction in the case, despite Energy Transfer's ( ET ) objections, since Greenpea...
zorazhuang/iStock via Getty Images A Dutch court said it could hear a case brought by Greenpeace against U.S. pipeline company Energy Transfer ( ET ), as the environmentalist group seeks compensation for U.S. cases in which it said it was targeted by the company, Reuters reported Wednesday. The court said it had jurisdiction in the case, despite Energy Transfer's ( ET ) objections, since Greenpeace is headquartered in the Netherlands. Greenpeace is suing Energy Transfer ( ET ) for what it says are "meritless" U.S. lawsuits by the company against groups that have protested against the Dakota Access pipeline project. Energy Transfer ( ET ) has said its cases against Greenpeace in the U.S. were to hold the group "accountable for its unlawful and damaging actions during the construction" of the Dakota Access pipeline. In February , a North Dakota judge confirmed an earlier verdict that ordered Greenpeace to pay the company $345M over its role in the Dakota Access protests. More on Energy Transfer Energy Transfer: The Drivers Behind Above-Average Growth This Year Energy Transfer Remains A Strong Buy After A Solid Q1 Performance Energy Transfer's Valuation Can't Be Justified In Light Of Its Surging NGL Exposure
NRx Pharmaceuticals ( NRXP ) on Wednesday announced the pricing of an underwritten public offering of 5.71M shares of its common stock, par value $0.001 per share at a public offering price of $3.50 per share of common stock. The company has also granted the underwriters a 30-day option to purchase up to an additional 857,142 shares of common stock. The gross proceeds of the offering will be about...
NRx Pharmaceuticals ( NRXP ) on Wednesday announced the pricing of an underwritten public offering of 5.71M shares of its common stock, par value $0.001 per share at a public offering price of $3.50 per share of common stock. The company has also granted the underwriters a 30-day option to purchase up to an additional 857,142 shares of common stock. The gross proceeds of the offering will be about $20 million. The offering is expected to close on June 4, 2026. The company currently intends to use the net proceeds from the offering for working capital and general corporate purposes to support its growth. Press Release More on NRx Pharmaceuticals NRx Pharmaceuticals: 'Sell' On ZYESAMI/NRX-101 Failures & Depression Market Uncertainty NRx Pharmaceuticals, Inc. (NRXP) Q1 2026 Earnings Call Transcript NRx Pharmaceuticals, Inc. (NRXP) Q4 2025 Earnings Call Transcript NRx Pharmaceuticals announces proposed public stock offering NRx Pharmaceuticals targets summer 2026 KETAFREE approval as it scales to 1M units per batch
AREC's EMCO procured its first battery shredding line, expanding lithium-ion battery recycling and advancing a domestic critical minerals supply chain.
AREC's EMCO procured its first battery shredding line, expanding lithium-ion battery recycling and advancing a domestic critical minerals supply chain.
New issue of the American Journal of Public Health focuses on parallels between marketing for cigarettes and UPFs The new issue of the American Journal of Public Health focuses on ultra-processed foods, and reveals that big tobacco companies used strategies that helped them sell cigarettes to sell ultra-processed food products, including Lunchables, geared toward children. The parallels between ul...
New issue of the American Journal of Public Health focuses on parallels between marketing for cigarettes and UPFs The new issue of the American Journal of Public Health focuses on ultra-processed foods, and reveals that big tobacco companies used strategies that helped them sell cigarettes to sell ultra-processed food products, including Lunchables, geared toward children. The parallels between ultra-processed foods (UPFs) and cigarettes include not only how UPF products were formulated and marketed to drive excess consumption, but also the growing body of evidence linking UPFs to a variety of health risks. For UPFs, these include cardiovascular diseases , certain cancers and cognitive health decline. Continue reading...
(RTTNews) - Accenture (ACN), the tech and consulting giant, Wednesday announced that it is investing in AlphaSense, an AI platform transforming market intelligence through Accenture Ventures.
(RTTNews) - Accenture (ACN), the tech and consulting giant, Wednesday announced that it is investing in AlphaSense, an AI platform transforming market intelligence through Accenture Ventures.
Luke Chan/E+ via Getty Images The stocks with the highest short interest are concentrated in micro- and small-cap consumer-facing names, particularly within personal care products and packaged foods and meat companies dominating bearish positioning. Among the most shorted stocks, Vital Farms ( VITL ) leads with 31.88% of shares outstanding sold short, signaling deep skepticism around its financial...
Luke Chan/E+ via Getty Images The stocks with the highest short interest are concentrated in micro- and small-cap consumer-facing names, particularly within personal care products and packaged foods and meat companies dominating bearish positioning. Among the most shorted stocks, Vital Farms ( VITL ) leads with 31.88% of shares outstanding sold short, signaling deep skepticism around its financial outlook and business sustainability. Other most short names include LifeVantage ( LFVN ) and Beyond Meat ( BYND) with short interest of 28.46% and 26.63%, respectively. In contrast, the least shorted names reflect relatively limited bearish positioning despite their smaller size and volatility. Here are the five most shorted consumer staple stocks with market capitalizations of up to $2B (as a percentage of shares outstanding): Vital Farms ( VITL ), Short interest: 31.88% LifeVantage ( LFVN ), Short interest: 28.46% Beyond Meat ( BYND ), Short interest: 26.63% Grocery Outlet ( GO ), Short interest: 24.49% Upexi ( UPXI ), Short interest: 24.01% Here are the five least shorted consumer staple stocks with market capitalizations of up to $2B (as a percentage of shares outstanding): Benson Hill ( BHILQ ), Short interest: 0.56% MedAvail ( MDVLQ ), Short interest: 0.65% Local Bounti ( LOCL ), Short interest: 0.75% Innovation Beverage Group ( IBG ), Short interest: 0.85% Laird Superfood ( LSF ), Short interest: 0.93% More on Vital Farms, LifeVantage, etc. Grocery Outlet Holding: Reiterate Sell Rating Given No Signs Of Strong Recovery Yet Laird Superfood, Inc. (LSF) Q1 2026 Earnings Call Transcript Grocery Outlet Holding Corp. (GO) Q1 2026 Earnings Call Transcript These 10 small-cap U.S. consumer staples companies rank among the market's most attractively valued stocks Highest and lowest quant-rated small-cap consumer staple stocks after earnings
A married couple filing jointly in the 24% federal bracket who pull in $80,000 in ordinary dividend income from a taxable brokerage will have to hand over $19,200 to the IRS every year. That is the entire cost of holding BDCs and mortgage REITs in the wrong account. Inside a Roth IRA, that same basket ... The Tax Math That Makes These Dividend Stocks Worth $19,200 More Inside a Roth
A married couple filing jointly in the 24% federal bracket who pull in $80,000 in ordinary dividend income from a taxable brokerage will have to hand over $19,200 to the IRS every year. That is the entire cost of holding BDCs and mortgage REITs in the wrong account. Inside a Roth IRA, that same basket ... The Tax Math That Makes These Dividend Stocks Worth $19,200 More Inside a Roth
eternalcreative/iStock via Getty Images In mid-May, Milestone Pharmaceuticals ( MIST ) reported first quarter earnings. The batter's whiff was big, almost astonishing: its Q1 GAAP EPS of .20 missed by 39 cents; its revenue of $.24 million missed by $37.4 million. The stock got shellacked in the aftermath and has continued to drift lower over the past three weeks. From $1.91 on the day of the earni...
eternalcreative/iStock via Getty Images In mid-May, Milestone Pharmaceuticals ( MIST ) reported first quarter earnings. The batter's whiff was big, almost astonishing: its Q1 GAAP EPS of .20 missed by 39 cents; its revenue of $.24 million missed by $37.4 million. The stock got shellacked in the aftermath and has continued to drift lower over the past three weeks. From $1.91 on the day of the earnings call, the ticker is now down 31%, trading at $1.33. At first glance, the market response appears warranted. MIST is a tiny ticker (market cap: $185 million), one that is exceptionally volatile and still jammed with 6.25% short interest. It can't disappoint like that. The question now is whether any further selloff is still warranted, or whether the stock has rightfully reached a point where it might stabilize, or even bounce. Milestone Pharmaceuticals Overview Founded in 2003 and based in both Montreal and Charlotte, Milestone Pharmaceuticals is a micro-cap biotech focused on advancing a specific cardiovascular therapy across two indications: PSVT (paroxysmal supraventricular tachycardia) --a disorder caused by abnormal electrical signaling in the heart, leading to sudden episodes of rapid heartbeat that begin and end abruptly. AFib-RVR (atrial fibrillation with rapid ventricular rate) -- a severe form of atrial fibrillation (and the most common cardiac arrhythmia) by which an irregular heartbeat accelerates dangerously, raising the risk of stroke, heart failure, and hospitalization. The firm has pursued a simple strategy: focus on two closely related disorders; develop versions of an already validated molecular class that preserve therapeutic efficacy while improving upon the pharmacokinetic behaviors. The hook: create a drug that acts fast and metabolizes quickly in the bloodstream to limit side effects. That approach culminated in "etripamil," Milestone's flagship therapy which received FDA approval on December 12, 2025. Now marketed under the name CARDAMYST, etripam...
Most investors hold Vanguard Total Bond Market ETF (NASDAQ:BND) because they want something boring in the portfolio, a sleeve that zigs when stocks zag. BND has become the default fixed-income holding for retirement accounts and three-fund portfolios across the country. The trouble is that the fund’s underlying construction has quietly stopped doing the job most ... Holding This Vanguard Bond ETF ...
Most investors hold Vanguard Total Bond Market ETF (NASDAQ:BND) because they want something boring in the portfolio, a sleeve that zigs when stocks zag. BND has become the default fixed-income holding for retirement accounts and three-fund portfolios across the country. The trouble is that the fund’s underlying construction has quietly stopped doing the job most ... Holding This Vanguard Bond ETF Is a Bad Idea in 2026. Buy This Instead.
ADP said U.S. businesses created 122,000 new jobs in May to mark the biggest increase in 16 months, another sign that points to an increase in hiring and a rebound in what’s been a very sluggish labor market.
ADP said U.S. businesses created 122,000 new jobs in May to mark the biggest increase in 16 months, another sign that points to an increase in hiring and a rebound in what’s been a very sluggish labor market.